Anzemet

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved February 1998

Specific Treatments:

prevention of nausea and vomiting associated with chemotherapy and surgery

Therapeutic Areas

General Information

Anzemet has been approved as an antiemetic that prevents nausea and vomiting associated with chemotherapy and surgery. Anzemet is available in both I.V. and oral formulations.